Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001490978-25-000059
Filing Date
2025-05-07
Accepted
2025-05-07 16:09:21
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-20250331.htm   iXBRL 10-Q 1565949
2 EX-10.1 sdgr-20250331xex101sixthar.htm EX-10.1 24760
3 EX-31.1 sdgr-20250331x10qex311.htm EX-31.1 9969
4 EX-31.2 sdgr-20250331x10qex312.htm EX-31.2 9999
5 EX-32.1 sdgr-20250331x10qex321.htm EX-32.1 4157
6 EX-32.2 sdgr-20250331x10qex322.htm EX-32.2 4182
  Complete submission text file 0001490978-25-000059.txt   7004757

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20250331.xsd EX-101.SCH 52608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sdgr-20250331_cal.xml EX-101.CAL 59787
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sdgr-20250331_def.xml EX-101.DEF 310104
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20250331_lab.xml EX-101.LAB 613358
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20250331_pre.xml EX-101.PRE 441053
75 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20250331_htm.xml XML 696194
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 25921401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)